What is the intrinsic value of BDTX?
As of 2025-07-04, the Intrinsic Value of Black Diamond Therapeutics Inc (BDTX) is
0.45 USD. This BDTX valuation is based on the model Peter Lynch Fair Value.
With the current market price of 2.60 USD, the upside of Black Diamond Therapeutics Inc is
-82.78%.
Is BDTX undervalued or overvalued?
Based on its market price of 2.60 USD and our intrinsic valuation, Black Diamond Therapeutics Inc (BDTX) is overvalued by 82.78%.
BDTX Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
0.45 - 0.45 |
0.45 |
-82.78% |
| P/E |
1.91 - 2.72 |
2.50 |
-3.7% |
| DDM - Stable |
0.58 - 3.64 |
2.11 |
-18.8% |
| DDM - Multi |
(1.63) - (8.57) |
(2.81) |
-207.9% |
BDTX Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
147.84 |
| Beta |
2.36 |
| Outstanding shares (mil) |
56.86 |
| Enterprise Value (mil) |
49.41 |
| Market risk premium |
4.60% |
| Cost of Equity |
9.47% |
| Cost of Debt |
5.00% |
| WACC |
6.57% |